We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...
Global Astrocytoma Market is valued approximately at USD 1.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2024-2032. Read the Market ...
New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells from patients with X-linked chronic ...
Shares of Incyte have risen 3.9% in the year-to-date period against the industry’s decline of 1.8%. Incyte primarily derives product revenues from the sales of its lead drug, Jakafi (ruxolitinib), in ...
A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...
Molecular Partners (MOLN) and Orano Med announced the oral presentation of the latest preclinical data supporting MP0712 as a Radio-DARPin ...
DelveInsight's ' Gene Therapy Competitive Landscape – 2024 ' report provides comprehensive global coverage of available, ...
Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction. If you don't have a login or your access has expired, you will need to ...
MADISON – Council members Eric Range and Melissa Honohan, Democrats who are running uncontested are making appeals to voters ...
Global Klinefelter Syndrome Therapeutics MarketThe global Klinefelter Syndrome Therapeutics Market is projected to surpass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback